|Articles|May 15, 2017
- Pharmaceutical Technology-05-15-2017
- Volume 2017 eBook
- Issue 1
Parallel Processing
Author(s)Agnes Shanley
Samsung BioLogics’ aggressive growth strategy begs the question: Are there lessons that US and European pharma might still learn from the electronics industry?
Advertisement
A look at how engineering-led companies from outside pharma are transforming biopharmaceutical contract services, and an interview with Samsung BioLogics’ vice president and head of business development, James Park, on the company’s history, culture, and plans.
Download
.
Articles in this issue
about 9 years ago
Clean, Disinfect, and Validateabout 9 years ago
Kill the Bioburden, Not the Biological Indicatorabout 9 years ago
Ensuring the Biological Integrity of Raw Materialsabout 9 years ago
Getting Biopharmaceutical Tech Transfer Right the First Timeabout 9 years ago
Case Study: Retrofitting Two New High-Purity Water Systemsabout 9 years ago
Single-Use Bioreactors Have Reached the Big Timeabout 9 years ago
Cost Considerations Drive Lean Technology in BiomanufacturingAdvertisement
Related Content
Advertisement
Advertisement
Advertisement